ARCHIVES

DCT Advisors Approve Increased Spending On Trials Monitoring

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For CLL

February 19, 2010

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011

Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds

March 28, 2003